Bionor Pharma is a leading vaccine company, searching for breakthrough treatments for HIV and other deadly viruses.

Modified Peptide based vaccinesen/Vaccines_+_technology/Platform_technology/The key to kill virusen/Vaccines_+_technology/Platform_technology/Vacc-4x kills virus producing cells.en/Vaccines_+_technology/HIV_vaccine_Vacc-4x/

Latest news

Hide mandatory notifications of trade

Invitation to Annual General Meeting 13 May 2015 Updated

Financial .2015

Oslo, 21 April 2015 - The Annual General Meeting of Bionor Pharma ASA will be held on Wednesday 13 May 2014, 11:00 a.m. at Hotel Continental, Stortingsgaten 24/26, Oslo

Change of Date for Q1 2015 Report and Annual General Meeting

Financial .2015

(Oslo 13 April 2015) Bionor Pharma ASA has changed the date for announcement for its first quarter 2015 results and Annual General Meeting to 13 May 2015.

Invitation to Annual General Meeting 13 May 2015

Financial .2015

Oslo, 13 April 2015 - The Annual General Meeting of Bionor Pharma ASA will be held on Wednesday 13 May 2014, 11:00 a.m. at Hotel Continental, Stortingsgaten 24/26, Oslo

Invitation to Annual General Meeting 13 May 2015 Updated

Financial .2015

Oslo, 21 April 2015 - The Annual General Meeting of Bionor Pharma ASA will be held on Wednesday 13 May 2014, 11:00 a.m. at Hotel Continental, Stortingsgaten 24/26, Oslo

Change of Date for Q1 2015 Report and Annual General Meeting

Financial .2015

(Oslo 13 April 2015) Bionor Pharma ASA has changed the date for announcement for its first quarter 2015 results and Annual General Meeting to 13 May 2015.

Invitation to Annual General Meeting 13 May 2015

Financial .2015

Oslo, 13 April 2015 - The Annual General Meeting of Bionor Pharma ASA will be held on Wednesday 13 May 2014, 11:00 a.m. at Hotel Continental, Stortingsgaten 24/26, Oslo

Go to news section

Featured content